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The messenger RNA of the intronless CEBPA gene is
translated into distinct protein isoforms through the
usage of consecutive translation initiation sites. These
translational isoforms have distinct functions in the
regulation of differentiation and proliferation due to
the presence of different N-terminal sequences. Here, we
describe the function of an N-terminally extended protein
isoform of CCAAT enhancer-binding protein a (C/EBPa)
that is translated from an alternative non-AUG initiation
codon. We show that a basic amino-acid motif within its
N-terminus is required for nucleolar retention and for
interaction with nucleophosmin (NPM). In the nucleoli,
extended-C/EBPa occupies the ribosomal DNA (rDNA)
promoter and associates with the Pol I-speciﬁc factors
upstream-binding factor 1 (UBF-1) and SL1 to stimulate
rRNA synthesis. Furthermore, during differentiation of
HL-60 cells, endogenous expression of extended-C/EBPa
is lost concomitantly with nucleolar C/EBPa immuno-
staining probably reﬂecting the reduced requirement for
ribosome biogenesis in differentiated cells. Finally, over-
expression of extended-C/EBPa induces an increase in cell
size. Altogether, our results suggest that control of rRNA
synthesis is a novel function of C/EBPa adding to its role as
key regulator of cell growth and proliferation.
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Introduction
Increased cell proliferation, for example in cancerous growth,
requires an increase in protein synthesis to fulﬁll the need for
extra cell mass. Stimulation of RNA polymerase I (Pol I)-
dependent ribosomal DNA (rDNA) transcription is a crucial
event in ribosome biogenesis, which is prerequisite for
enhanced protein synthesis (Ruggero and Pandolﬁ, 2003).
In recent years, a growing number of RNA polymerase II (Pol
II)-dependent transcription factors have been found to reg-
ulate RNA Pol I-dependent rDNA transcription in addition.
These transcription factors either stimulate rRNA synthesis
during proliferation like c-Myc (Arabi et al, 2005; Grandori
et al, 2005) or inhibit rRNA synthesis as has been shown for
CTCF (Torrano et al, 2006) and the lineage-speciﬁc transcrip-
tion factors MyoD, myogenin and CCAAT enhancer-binding
protein b (C/EBPb) that selectively interact with rRNA genes
during differentiation (Ali et al, 2008).
C/EBPacontrols cell proliferation as well as transcription of
genes involved in differentiation and energy homeostasis in
various cell types through redundant as well as speciﬁc
functions compared with C/EBPb and other C/EBP family
members (Nerlov, 2007). In the haematopoietic system, C/
EBPa is required for the differentiation of myelomonocytic
cells, and mutations in the CEBPA gene are considered to be
critically involved in the etiology of about 10% of human
acute myeloid leukemia (AML) (Nerlov, 2004; Kirstetter et al,
2008). A pivotal mechanism that controls C/EBPa expression
in the cell is the regulated translation of its intronless mes-
senger RNA into three functionally different protein isoforms
from three successive translation initiation sites (Ossipow
et al, 1993; Calkhoven et al, 2000) (Figure 1A). The full-
length-C/EBPa isoform (p42) that is translated from the ﬁrst
AUG codon in the C/EBPa reading frame is a complete
transcription factor possessing all sequences for transactiva-
tion of genes and for inhibition of proliferation (Ossipow et al,
1993). In contrast, the truncated-C/EBPa isoform (p30),
which is translated from an internal AUG codon, lacks the
amino-terminal sequences for transactivation and is unable to
restrict proliferation probably due to the absence of sequences
required for the inhibition of E2F-dependent target genes (Lin
et al, 1993; Porse et al, 2001). An evolutionary conserved
upstream open reading frame (uORF) in the mRNA leader
sequence controls the ratio between the full-length (p42) and
truncated (p30) C/EBPa isoforms. Because of the cis-regula-
tory uORF, translation of the C/EBPa isoforms is under the
control of the mTOR kinase-mediated regulation of eukaryotic
initiation factor (eIF) 4E as well as the stress-induced eIF2a-
kinase family (Calkhoven et al, 2000). Differential expression
of the translational isoforms of C/EBPa provides a versatile
mechanism to deliver functions on demand. However, it
seems also to provide a critical target for deregulation and
mutation during cancer development as is illustrated by a
mouse model for the frequent mutation in human AML (Pabst
et al, 2001) that results in the synthesis of only the truncated-
C/EBPa isoform and causes AML with complete penetrance
(Kirstetter et al, 2008).
The function of the extended-C/EBPa isoform, which is
translated from an upstream non-AUG codon has never been
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897experimentally addressed. In this study, we reveal a novel
function of C/EBPa that is speciﬁc for the extended isoform.
We show that the extended-C/EBPa isoform can localize to
nucleoli where it binds to the rDNA promoter. The extended-
C/EBPa isoform interacts with and facilitates the recruitment
of the Pol I-speciﬁc transacting factor upstream-binding factor 1
(UBF-1) and components of the TATA-binding protein (TBP)–
TBP-associated factor (TAFI) complex SL1, and it enhances
acetylation of histone H3 and H4 at the rDNA promoter.
Furthermore, its nucleolar localization results in an increase
in cell size. We identiﬁed a motif within the additional amino-
terminal domain of the extended isoform that serves as a
nucleolar localization signal (NoLS) and is required for
interaction with nucleophosmin (NPM). In addition to the
NoLS, a phosphorylation-mimicking mutation of a speciﬁc
serine residue (S299D) strongly stimulates nucleolar reten-
tion, indicating that nucleolar retention of extended-C/EBPa
may be further regulated through phosphorylation. We also
show that downregulation of endogenous expression of
extended-C/EBPa on phorbolester-induced differentiation
of HL-60 cells correlates with loss of C/EBPa-speciﬁc nucleo-
lar staining. Our data further strengthens the concept that
regulated translation of the C/EBPa mRNA into protein iso-
forms with distinct functions is a key-regulatory mechanism
in the control of proliferation and differentiation in C/EBPa
expressing cells.
Results
Extended-C/EBPa is translated from a non-AUG
alternative initiation codon
Amino-acid sequence comparison reveals a high degree of
conservation among mammals of the region upstream of the
ﬁrst AUG-codon in the C/EBPa coding frame as exempliﬁed
in Figure 1B for the murine and human C/EBPa cDNAs. For
murine C/EBPa, these N-terminally extended sequences can
be incorporated into the C/EBPa proteins through initiation
from one of the two successive CUG alternative initiation
codons (A-sites in Figure 1A) that lie  28 and  37 codons
upstream of the ﬁrst AUG (site B in Figure 1A) of the C/EBPa
coding frame (Calkhoven et al, 2000) (and data not shown).
In case of the human sequence, a GUG alternative initiation
codon is found at position  35. Mutation of the most
prominently used CUG codon (DA
2) in the rat C/EBPa
cDNA or the GUG codon (DA
1) in the human C/EBPa
cDNA as well as removal of the complete sequence upstream
of the ﬁrst AUG (D50) result in complete loss of extended-
C/EBPa expression in COS-1 cells (Figure 1C). Conversely,
converting the CUG or GUG codons into a proper AUG codon
(A
opt) results in predominant expression of the
extended isoform (Figure 1C). Hence, alternative CUG or
GUG codons in the 50-leader sequence of C/EBPa mRNAs
can be used for initiation of translation.
The extended-C/EBPa isoform is retained in the
nucleolus
C/EBPa is a transcription factor that predominantly localizes
to the nucleus. It contains a bipartite nuclear localization
signal (NLS) within its carboxy-terminal basic region that is
present in all three translational isoforms (Williams et al,
1997). To compare the subcellular distribution between the
three translational isoforms of C/EBPa, we examined their
cellular localization by ﬂuorescence microscopic analysis
using the Zeiss ApoTome system. For this purpose, we
transfected C33A cells with expression constructs containing
sequences for the separate C/EBPa isoforms or constructs
with the C/EBPa isoforms fused at their carboxy-termini to
enhanced green ﬂuorescent protein (EGFP). We found that
in a consistent percentage (10%) of transfected cells, the
extended-C/EBPa isoform localized to the nucleoli as was
detected by either direct (Figure 2A) or indirect ﬂuorescence
(see Supplementary Figure S1). Nucleolar localization was
veriﬁed by co-immunostaining of the nucleolar marker pro-
tein Fibrillarin, which is a component of the rRNA processing
machinery. In contrast, nucleolar localization was never
observed with transient expression of the full-length- or
truncated-C/EBPa isoforms, indicating that nucleolar locali-
zation is a speciﬁc feature of the extended-C/EBPa isoform.
Interestingly, during the establishment of C33A cell lines that
stably express extended-C/EBPa, the percentage of cells with
nucleolar retention continuously raises up to 100%, in long-
term cultures, suggesting that these cells have a selective
proliferation or survival advantage (data not shown).
NoLSs are often characterized by stretches of basic amino
acids (Carmo-Fonseca et al, 2000; Emmott and Hiscox, 2009).
The extended-C/EBPa domain contains a conserved RRXR
motif that is also found in proven NoLSs of other proteins like
Parp2, p14/19Arf, ING1b, Rpp29 or HIV Tat (Kubota et al,
1989; Jarrous et al, 1999; Weber et al, 1999; Scott et al, 2001;
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Figure 1 The extended-C/EBPa isoform is translated from a non-
AUG codon. (A) Schematic representation of the C/EBPa messenger
RNAwith three alternative translation initiation sites, indicated as A
(CUG or GUG), B (AUG) and C (AUG), and the initiation site for the
cis-regulatory uORF, indicated as D (AUG), respectively. The mRNA
can be translated into three separate protein isoforms extended-
(Exta), full-length- (Fla) or truncated-C/EBPa (Tra) that contain
different sets of the functional domains TAD (Transactivation
Domain), BD (Basic Domain) and LZ (Leucine Zipper). (B)
Amino-acid sequence comparison of the extended domains of rat,
mouse and human C/EBPa; conserved amino-acid residues are
shaded in grey. (C) Immunoblots comparing expression from
wild-type and mutant rat (rC/EBPa) and human (hC/EBPa)C /
EBPa constructs in COS-1 cells: Wild-types (wt), mutants lacking
the translation initiation site A (DA
1/2), constructs devoid of the
50leader (D50), and constructs with the CUG or GUG exchanged by
an AUG codon (A
opt).
Nucleolar function of C/EBPa
CM u ¨ller et al
The EMBO Journal VOL 29 | NO 5 | 2010 &2010 European Molecular Biology Organization 898Meder et al, 2005) (Figure 2B). To examine whether the
extended domain is required and sufﬁcient for nucleolar
retention, we fused the 28 amino acids of the extended
domain to EGFP and determined cellular localization by
microscopic analysis. Figure 2C shows that the sequences
of the extended C/EBPa domain alone are very efﬁcient in
retaining the attached EGFP in the nucleolus in almost 100%
of transfected cells. In contrast, the mutation of the RRQR
motif into AAAA abolished nucleolar localization of the
extended domain EGFP fusion construct and resulted in
even distribution over the cell similar to the EGFP control.
Hence, nucleolar localization is a unique feature of the
extended-C/EBPa isoform and the RRXR NoLS-motif within
the extended domain of C/EBPa is required for its nucleolar
retention.
Pseudo-phosphorylation of serine 299 of extended-
C/EBPa stimulates nucleolar retention
The observation that transiently expressed extended-C/EBPa
is retained in the nucleoli in a portion of cells, yet unrest-
rained nucleolar retention can be achieved with the sole
EGFP-fused extended domain indicates that nucleolar reten-
tion of the whole protein may be subject of further regulation.
It has been shown for other proteins with partial nucleolar
localization like Parp2 or ING1b that in addition to the RRXR
motif also their NLSs contributed to the efﬁciency of nucleo-
lar retention independent from their function for nuclear
localization (Scott et al, 2001; Meder et al, 2005). We, there-
fore, examined the effect of different mutations within the
bipartite NLS of C/EBPaand identiﬁed a serine residue within
the NLS (S299 in full-length-C/EBPa) whose mutation into a
phosphorylation-mimicking aspartate causes efﬁcient nucleo-
lar retention. Table I presents data from triplicate transfection
experiments in four cell lines (C33A, HEK293, COS-1, HeLa)
showing that in all cell lines, the S299D mutation rendered
nucleolar retention to virtually 100% of transfected cells,
compared with around 10% nucleolar versus 90% nucleo-
plasmic staining for the wt extended-C/EBPa-EGFP. Mutation
of the RRQR NoLS-motif in the extended-C/EBPa
S299D-EGFP
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Figure 2 Nucleolar localization of the extended-C/EBPa isoform. (A) Subcellular localization of extended- (Exta), full-length- (Fla)o r
truncated- (Tra) C/EBPa proteins fused to EGFP after transient transfection in C33A cells. DNAwas stained with DAPI to visualize the nucleus
and immunostaining with the Fibrillarin-speciﬁc antibody served to locate the nucleolus. (B) Alignment of the RRXR motifs within the domains
mediating nucleolar localization of extended-C/EBPa and other proteins with known nucleolar localization. (C) Subcellular localization of the
isolated extended domain of C/EBPa either harbouring the wt sequence (Exta-Dom) or a mutation of its RRQR motive (Exta-DomDNoLS) fused
to EGFP. Bars, 10mm.
Table I Number of cells with nucleolar staining per 100 EGFP-
positive cells
Exta
wt-EGFP Exta
S299D-EGFP Exta
S299DDNoLS-EGFP
C33A 11 9 11 99 100 99 0 0 0
HEK293 13 12 11 99 99 98 0 0 0
COS-1 11 11 10 100 99 100 0 0 0
HeLa 7 7 9 94 94 93 0 0 0
Counts were obtained from three independent transfection experi-
ments.
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cases. Notably, we did not score a single cell with nucleolar
localization of full-length- or truncated-C/EBPa
S299D-EGFP
fusion proteins either with or without the S299D mutation
during the examination of all the cell lines. Figure 3A shows a
typical example for all C/EBPa
S299D-EGFP isoforms in C33A
cells and Figure 3B shows nucleolar retention for extended-
C/EBPa
S299D-EGFP in ﬁve additional cell lines. Mutation of
the serine 299 into alanine did not stimulate nucleolar reten-
tion of the extended-C/EBPa-EGFP fusion protein or the
extended-C/EBPa isoform (data not shown). Similar results
were obtained by immunostaining of cells transfected with
expression constructs for native C/EBPa isoforms without
EGFP (Supplementary Figure S2A). Although, a similar ex-
tended isoform of the related C/EBPb exists that is translated
from an upstream AUG-codon, it does not have a NoLS, and
ExtαS299D
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FlαS299D
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Figure 3 Pseudo-phosphorylation of serine 299 in extended-C/EBPa stimulates its nucleolar retention. (A) Subcellular distribution of S299D
mutants of extended- (Exta
S299D), extended DNoLS (Exta
S299DDNoLS), full-length- (Fla
S299D) or truncated-C/EBPa (Tra
S299D) proteins fused to
EGFP. (B) Nucleolar retention of extended-C/EBPa
S299D in HeLa, COS-1, Hek293T, MEF and U2OS cells. C/EBPa
S299D-EGFP constructs were
transiently transfected into the different cell lines and subcellular localization was analysed as described in Figure 2. Bars, 10mm.
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nucleolus whether it harbours an S239D mutation that corre-
sponds to the S299D mutation in C/EBPa or not (data not
shown). Hence, our data suggest that nucleolar retention of
extended-C/EBPa is cell-type independent, requires the RRQR
NoLS-motif in the extended domain and is enhanced by
phosphorylation of serine 299 within the NLS.
Endogenous C/EBPa localizes to the nucleolus
in myelomonocytic cells
The promyelocytic human leukemia cell line HL-60 has
retained the capacity to differentiate in cell culture and is
one of the few cell lines that express endogenous C/EBPa.
Immunoblot analysis conﬁrmed that proliferating and undif-
ferentiated HL-60 cells express all three C/EBPa translational
isoforms, depicted extended-, full-length- and truncated-
C/EBPa (Figure 4A). Intriguingly, indirect ﬂuorescent immu-
nostaining of C/EBPa in HL-60 cells using four different anti-
C/EBPa antibodies revealed a prominent staining of the
nucleoli in addition to the expected nuclear staining
(Figure 4B; Supplementary Figure S3A). Induction of macro-
phage differentiation by phorbolester (TPA) treatment re-
sulted in complete disappearance of the C/EBPa-speciﬁc
staining of the nucleoli although staining of the remaining
part of the nucleus remained unchanged (Figure 4B).
Immunoblotting revealed that the expression of the extended-
and truncated-C/EBPa isoforms were speciﬁcally downregu-
lated in the differentiated HL-60 cells (Figure 4A). Hence, loss
of expression of the extended-C/EBPa isoform correlates with
loss of nucleolar staining. C/EBPa-speciﬁc nucleolar staining
was also found in another human leukemia cell line, the
promonocytic U937 cell line (Supplementary Figure S3B
and C).
Extended-C/EBPa interacts with Pol I-speciﬁc factors
and its nucleolar retention depends on ongoing rDNA
transcription
The nucleolus is the place where rDNA transcription is
performed through the activity of RNA Pol I. The nucleolar
transcription factor UBF-1 is a crucial component of the RNA
Pol I preinitiation complex (Grummt, 2003). Immuno-
ﬂuorescence microscopy revealed that ectopically expressed
extended-C/EBPa
S299D but not the corresponding DNoLS
mutant localizes with endogenous UBF-1 in the nucleoli
(Supplementary Figure S4A). To examine whether C/EBPa
interacts with UBF-1, HEK293 cells were transfected with
expression plasmids for extended-, full-length or truncated-
C/EBPa, respectively, followed by co-immunoprecipitation
(Co-IP) experiments. We found that both wt and the S299D
mutant of extended-C/EBPa (Figure 5A) as well as full-
length-C/EBPa (Figure 5B) can be co-precipitated together
with endogenous UBF-1 using anti-UBF-1 antibodies. In con-
trast, we could not detect a clear co-precipitation of trun-
cated-C/EBPa.
RNA Pol I transcription requires the SL1 complex, which is
composed of the TBP and three Pol I-speciﬁc TAFs, TAFI110,
TAFI63 and TAFI48. SL1 was shown to be essential for UBF-1
recruitment and pre-initiation complex formation (Friedrich
et al, 2005). As full-length C/EBPa is known to bind to and
recruit TBP to Pol II promoters (Nerlov and Ziff, 1995), we
examined whether extended-C/EBPa interacts with TBP and
TAFI48. Co-IP using anti-C/EBPa antibodies resulted in pre-
cipitation of TBP by extended-C/EBPa, as well as the S299D
and the S299D-DNoLS mutant thereof (Figure 5C). Hence,
interaction with TBP is a genuine property of both full-length
and extended-C/EBPa. In addition, we could co-precipitate
extended-C/EBPa
S299D with anti-TAFI48 antibodies; however,
co-precipitation was not seen with the DNoLS mutant
(Figure 5D, upper panel). Furthermore, TAFI48 can be pre-
cipitated with anti-TBP antibodies more efﬁciently in cells
that express extended-C/EBPa, in particular the S299D mu-
tant, compared with DNoLS or empty vector controls
(Figure 5D, lower panel). Overall these results indicate that
extended-C/EBPa, UBF-1, and TBP and TAFI48 as part of the
SL1 complex reside as a complex in the nucleolus.
It has been shown that the RRQR motif in Parp2 is required
for nucleolar retention and for interaction with NPM (also
known as B23) (Meder et al, 2005), a ubiquitously expressed
phosphoprotein with multiple functions that constantly shut-
tles between the nucleolus, nucleoplasm and cytoplasm
(Grisendi et al, 2006). To examine whether a similar interac-
tion between NPM and C/EBPa exists, Co-IP experiments
were set up and as presented in Figure 5E, NPM could only be
co-immunoprecipitated with wt and the S299D mutant of
extended-C/EBPa while co-imunoprecipitation failed with
the DNoLS mutant or full-length isoform that both lack
RRQR motif.
Typically, nucleolar retention of regulatory factors depends
on ongoing rDNA transcription. To examine whether nucleo-
lar localization of the extended-C/EBPa
S299D mutant depends
on ongoing rDNA transcription, we analysed its localization
in the presence of a low concentration of actinomycin D
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Figure 4 C/EBPa isoform expression and subcellular localization
on phorbolester (TPA)-induced monocytic differentiation of HL-60
cells. (A) Immunoblot showing endogenous expression of the
extended- (Exta), full-length- (Fla) and truncated-C/EBPa (Tra)
hC/EBPa isoforms in untreated proliferating HL-60 cells and after
treatment with 200nM phorbolester (TPA) for 12h. a-tubulin
staining in the lower blot serves as loading control.
(B) Immunostainings of TPA-treated cells (þTPA) and control
cells (Solvent) were performed with an anti-C/EBPa antibody
against a C-terminal epitope (14AA). DNA was stained with DAPI
to visualize the nucleus and immunostaining with a Fibrillarin-
speciﬁc antibody served to located the nucleolus. Bars, 10mm.
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tion (Perry and Kelley, 1970). As shown in Figure 6 and
Supplementary Figure S4B, nucleolar localization of ex-
tended-C/EBPa
S299D was lost in the presence of actinomycin
D, whereas inhibition of RNA Pol II driven transcription with
a-amanitin had no effect on the localization of the extended
isoform. Taken together, these results show that extended-
C/EBPa interacts with functional nucleolar proteins, UBF-1 and
NPM, and the SL1 components TBP and TAFI48, and that its
nucleolar retention depends on ongoing rDNA transcription.
Extended-C/EBPa stimulates RNA Pol I-dependent
rRNA synthesis
As C/EBPa is a transcription factor, we examined whether
extended-C/EBPa was able to regulate RNA Pol I-mediated
rRNA synthesis as has been shown also for other RNA Pol II-
dependent transcription factors, including c-Myc (Arabi et al,
2005; Grandori et al, 2005). To address this question, we co-
transfected a human rRNA minigene reporter construct
(pMr1930-BH) (Mayer et al, 2005) together with expression
vectors for extended-C/EBPa in HEK293Tcells. We observed
that overexpression of both extended-C/EBPa and the S299D
mutant thereof strongly induced RNA Pol I-mediated tran-
scription of the reporter RNA to a similar extent as c-Myc,
which was used as a positive control (Figure 7A). To examine
whether extended-C/EBPa is able to stimulate endogenous
rDNA transcription, we analysed the expression levels of 45S
pre-rRNA by Northern blotting in long-term C33A cell lines
that stably express extended-, full-length- or truncated-
C/EBPa wt proteins, the S299D mutants thereof and DNoLS
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Figure 5 Extended-C/EBPa interacts with UBF-1, SL1 and NPM. Immunoprecipitations (IPs) were performed with speciﬁc antibodies or with
mouse IgG as control from total lysates of HEK293 cells expressing one of the C/EBPa isoforms encoded: wild type (wt) extended-C/EBPa (Exta
or Ext), extended-C/EBPa
S299D (SD), extended-C/EBPa
S299DDNoLS (DN), full-length-C/EBPa (Fl), truncated-C/EBPa (Tr). Immunoblots of
immunoprecipitates (IP) and total lysates (Input) were stained as indicated. (A) Extended-C/EBPa co-precipitates with UBF-1 using anti-UBF-1
antibodies (B) extended- and full-length-C/EBPa but not truncated-C/EBPa co-precipitate with UBF-1 using anti-UBF-1 antibodies.
Immunoglobulin light chain is marked by IgGL. (C) TBP co-precipitates with extended-C/EBPa using anti-C/EBPa antibodies.
Immunoglobulin heavy chain is marked by IgGH. (D) Extended-C/EBPa
S299D but not the DNoLS mutation co-precipitates with TAFI48 using
anti-TAFI48 antibodies (upper panel). TAFI48 co-precipitates more efﬁciently with TBP using anti-TBP antibodies only in cells expressing
extended-C/EBPa
S299D (lower panel). (E) NPM co-precipitates with extended-C/EBPa
S299D but not with the extended-C/EBPa
S299DDNoLS using
anti-C/EBPa antibodies.
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C/EBPa and extended-C/EBPa
S299D results in increased levels
of endogenous 45S pre-rRNA compared with the empty
vector control. In contrast, expression of the full-length- or
truncated-C/EBPa isoforms either with or without the S299D
mutation was not able to enhance 45S pre-rRNA levels. The
DNoLS mutation prevents induction of 45S pr-RNA
(Figure 7C). To examine a possible indirect Pol II-dependent
regulation of rDNA transcription by extended-C/EBPa, 45S
pre-rRNA levels were analysed under inhibition of Pol II by a-
amanitin (50mg/ml). The results in Figure 7D show that
inhibition of Pol II only slightly affected induction of 45S
pre-rRNA, suggesting a direct regulation of Pol I by extended-
C/EBPa. To examine whether selective elimination of ex-
tended-C/EBPa impedes rRNA synthesis, we knocked-down
expression of endogenous C/EBPa in HL-60 cells by intro-
duction of lentiviral human C/EBPa-speciﬁc shRNA
(Figure 8A). Subsequently, in the C/EBPa knock-down
cells, expression was restored from retrovirally transduced
constructs coding for all three C/EBPa-FLAG isoforms, or
from a construct with a DCUG mutation avoiding expression
of the extended-C/EBPa isoform (Figure 8B). As demon-
strated by Northern analysis, 45S pre-rRNA levels were
only signiﬁcantly stimulated in the presence of extended-
C/EBPa and not when full-length- and truncated-C/EBPa are
expressed alone from the DCUGa construct. Once more, the
requirement of the N-terminal NoLS was demonstrated as
stimulation of 45S pre-rRNA levels by overexpression of
extended-C/EBPa
S299D alone is abrogated when NoLS is
mutated (Figure 8C). Taken together, extended-C/EBPa di-
rectly and speciﬁcally enhances rDNA transcription, which
depends on nucleolar retention mediated by the N-terminally
located NoLS.
Bioinformatic analysis revealed two C/EBP-binding motifs
in the intergenic spacer of the human rDNA repeats
(Figure 9A). One of the C/EBP-binding motifs lies 25bp
upstream of the transcription start, in the same proximal
promoter sequences that are crucial for Pol I regulation by
c-Myc (Figure 9A; region Cp, same as region 42.9 in Grandori
et al, 2005). Chromatin immunoprecipitation (ChIP) experi-
ments using anti-C/EBPa antibodies revealed that extended-
C/EBPa occupies this rDNA promoter segment (Figure 9B;
upper chart, region Cp) in C33A cells. Notably, the more
efﬁcient nucleolar retention of extended-C/EBPa
S299D results
in recovery of more Cp DNA fragments whereas the DNoLS
mutation abolishes DNA recovery (Figure 9B and C).
In addition, extended-C/EBPa binds to a more distal region
containing the second C/EBP-binding motif (Figure 9A and B;
upper chart, region Cd). Extended-C/EBPa does not interact
with region M that does not contain a C/EBP-binding motif,
which, however, was shown to be implicated in c-Myc-
dependent regulation (Figure 9A and B; region M, same as
region 42 in Grandori et al, 2005).
Region Cp covers the Pol I promoter and is also heavily
occupied by UBF-1, as was also observed by others
(Figure 9B, lower chart, region Cp) (Grandori et al, 2005;
here region 42.9). Interestingly, the enhanced interaction of
extended-C/EBPa
S299D with the regions Cp and Cd improves
recruitment of UBF-1 to these regions (Figure 9B and C).
To investigate whether extended-C/EBPa also facilitates the
recruitment of components of the SL1 complex to the rDNA
promoter, we performed a ChIP assay using an anti-TBP
antibody. Figure 9D shows that indeed recruitment of TBP
is enhanced on extended-C/EBPa binding to region Cp. c-Myc
like extended-C/EBPa binds most strongly to region Cp and
stimulates histone H3 and H4 acetylation especially at the
neighbouring region M (Grandori et al, 2005). C/EBPa is
known to activate transcription from Pol II promoters through
recruitment of histone acetylases (Erickson et al, 2001;
Bararia et al, 2008). ChIP analysis using anti-histone H3 or
H4 antibodies revealed that histone acetylation is enhanced
particularly at site M and to a lesser extend to Cp when
extended-C/EBPa binds to the rDNA promoter (Figure 9E).
Hence, our results suggest that the occupation of the rDNA
promoter region by extended-C/EBPa facilitates recruitment
of UBF-1 and SL1, and induces histone acetylation.
Overexpression of extended-C/EBPa results in
an increase in cell size
Increase in cell size is a well-known consequence of en-
hanced ribosome biogenesis (Baserga, 2007), and the stimu-
lation of rRNA synthesis by c-Myc has been associated with
increased cell size in different systems (Oskarsson and
Trumpp, 2005). Cell volume analysis of the stably transfected
cells revealed that expression of extended-C/EBPa
wt- and in
particular the extended-C/EBPa
S299D isoform results in a
profound increase in the mean cell volume, whereas the
other isoforms show no effect (Figure 10). C33A cells lack a
functional Brahma protein as part of the SWI/SNF chromatin-
remodelling complex, which is required for C/EBPa-induced
proliferation arrest (Mu ¨ller et al, 2004). To study whether the
absence of Brahma is instrumental in the pronounced in-
crease in cell volume, we analysed C33A cells in which
Brahma function was restored by expression from a retroviral
construct compared with dominant negative mutant of
Brahma and empty vector. In none of the situations, however,
cell size was affected (Supplementary Figure S5A). Hence,
Brahma function has no effect on cell size. In addition, over-
expression of extended-C/EBPa
wt- and the extended-
C/EBPa
S299D isoform in HEK293 cells that have a functional
+ Actinomycin D
(50 ng/ml)
+ α-Amanitin
(50 μg/ml)
+ Solvent
ExtαS299D-
EGFP Fibrillarin DNA Overlay
Figure 6 Nucleolar retention of extended-C/EBPa depends on
ongoing rDNA synthesis. Blocking RNA polymerase I activity
with actinomycin D (50ng/ml) abrogates nucleolar retention of
extended-C/EBPa
S299D, whereas blocking RNA polymerase II with
a-amanitin (50mg/ml) or solvent treatment has no effect. C33A cells
transiently transfected with extended-C/EBPa
S299D-EGFP were trea-
ted for 2h as indicated and subcellular localization was analysed as
described in Figure 2. Bars, 10mm.
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nounced increase in cell size (Supplementary Figure S5B).
Discussion
In this study, we reveal a novel function of the transcription
factor C/EBPa that is speciﬁc for the translational protein
isoform called extended-C/EBPa. Results presented in this
manuscript provide evidence that extended-C/EBPa localizes
in the nucleoli and stimulates RNA Pol I-dependent rDNA
transcription, and concomitantly increases cell size.
Regulation of Pol I activity and rRNA synthesis
by C/EBPa
We show an increase in rRNA levels from endogenous loci
and increased Pol I transcription from an rRNA minigene
reporter in response to extended-C/EBPa expression. These
ﬁndings are supported by ChIP assays that revealed interac-
tion of extended-C/EBPa with rDNA promoter sequences.
Furthermore, expression of extended-C/EBPa results in in-
creased acetylation of histones H3 and H4 within the rDNA
promoter, reﬂecting enhanced promoter activation through
recruitment of acetyltransferases. Finally, our results suggest
that extended-C/EBPa stimulates Pol I pre-initiation complex
formation as extended-C/EBPa interacts with UBF-1 and
components of the SL1 complex, and facilitates their recruit-
ment to rDNA promoter sites. Remarkably, similar functions
have also been described for c-Myc (Arabi et al, 2005;
Grandori et al, 2005). Indeed, both proteins can bind to the
proximal promoter region (region Cp), recruit the same set of
factors and induce histone acetylation in the same region M.
Other RNA Pol II transcription factors like Runx2, MyoD,
Myogenin and C/EBPb interact with rRNA genes, yet repress
rRNA synthesis during differentiation (Grandori et al, 2005;
Young et al, 2007; Ali et al, 2008). These inhibitory factors
contact the rRNA promoter during mitosis when the nucleolar
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Figure 7 Extended-C/EBPa stimulates RNA Pol I-dependent rDNA transcription. (A) Hek293T cells were transiently transfected with the
human rRNA minigene reporter construct pHrP2-BH together with expression constructs for wild type extended-C/EBPa (wt), the extended-
C/EBPa
S299D (S
299D) mutant, the latter fused to EGFP (S
299D EGFP), c-Myc or the empty vector (Vec) as control as indicated. Half of the cells
were analysed for transcription from the rRNA minigene reporter by Northern blotting using 10mg of total RNA and a construct-speciﬁc probe.
The other half of the cells were used for protein analysis. (B) The levels of the endogenous 45S rRNA precursor in C33A cells stably expressing
wild type (wt) extended-, full-length-, truncated-C/EBPa or the S229D mutants thereof (S
299D), or the empty vector as control was analysed by
Northern blotting from 30mg of total RNA. (C) The levels 45S rRNA precursor in C33A cells stably expressing wild type (wt) extended-C/EBPa
or the S229D or DNoLS mutants thereof, or the empty vector as control was analysed by Northern blotting from 30mg of total RNA. (D) The
levels 45S rRNA precursor in C33A cells stably expressing wild type (wt) extended-C/EBPa, the S229D mutant or the empty vector as control
untreated or treated with 50mg/ml a-amanitin (a-am) was analysed by Northern blotting from 30mg of total RNA. A human b-actin probe or
ethidium bromide (EtBr) inverted staining of the gel was used for loading control. Total protein extracts of the cells were blotted for detection of
expression of C/EBPa with anti-C/EBP antibodies or expression of c-Myc, with anti-Myc antibodies as indicated.
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making nucleolar retention signals dispensable. This stands
in contrast to the activating function of extended-C/EBPa that
requires the NoLS for rDNA promoter binding and stimula-
tion of rRNA synthesis.
We show that besides extended- also full-length-C/EBPa
interacts with UBF-1. In contrast to the extended isoform,
full-length-C/EBPa is not retained in the nucleoli and rather
seems to inhibit rRNA synthesis (Figures 2A and 7B; data not
shown). Interestingly, the Pol I inhibitory factors Runx2,
MyoD and Myogenin also interact with UBF-1 (Young et al,
2007; Ali et al, 2008). Although the observed repression by
full-length-C/EBPa could be caused indirectly by its anti-
proliferative activities, or through sequestration of UBF-1
within the nucleoplasm, it may inhibit rRNA synthesis invol-
ving direct rDNA promoter interaction similarly to Runx2,
MyoD or Myogenin. Such a direct interaction of full-length
C/EBPa with the rDNA promoter is likely as we recovered
promoter rDNA (region Cp) in ChIP analysis using both anti-
UBF-1 as well as anti-C/EBPa antibodies from proliferating
HL-60 cells expressing all translational C/EBPa isoforms as
well as from differentiating HL-60 cells, which express only
the full-length C/EBPa isoform (data not shown).
Extended-C/EBPa expression results in an increased
cell size
Overexpression of extended-C/EBPa, in particular of the
S299D mutant that shows augmented nucleolar retention
and Pol I activation, results in a pronounced increase in cell
volume. Obviously, cell growth (increase in cell size) requires
an enhanced protein biosynthesis rate, which directly de-
pends on ribosome biogenesis with rRNA synthesis as the
rate-limiting process. Accordingly, other positive regulators of
Pol1-dependent rRNA transcription like c-Myc (Oskarsson
and Trumpp, 2005) and IRS-1 (Valentinis et al, 2000; Sun
et al, 2003) are able to increase cell size in speciﬁc systems.
Speciﬁc nucleolar retention of the extended-C/EBPa
isoform
Extended-C/EBPa is the only translational C/EBPa isoform
that can be retained in the nucleoli. This can be explained by
the presence of a conserved RRXR nucleolar localization
(NoLS) motif in the N-terminal part of the protein that is
also found in other nucleolar-retained factors (Kubota et al,
1989; Jarrous et al, 1999; Weber et al, 1999; Zhang and Xiong,
1999; Scott et al, 2001; Meder et al, 2005). For both Parp2 (Li,
1997; Meder et al, 2005) and extended-C/EBPa (this study),
the RRXR motif is required for interaction with NPM (also
known as B23), which could mean that either these factors
need to be nucleolar to interact with NPM or that they are
recruited to the nucleolus through binding to NPM. NPM is
implicated in cancer pathogenesis as it is over-expressed in a
diversity of solid tumours, and in several haematologic malig-
nancies the NPM1 gene is found mutated or rearranged (Falini
et al, 2007). Therefore, it would be interesting to examine
whether cancerous mutations of NPM have an effect on func-
tions of C/EBPa in the control of cell proliferation and growth.
Apart from the RRXR motif, we observed that a phospho-
rylation-mimicking mutation of a Serine residue within the
NLS (S299 as numbered for the full-length isoform) strongly
enhances nucleolar retention of extended-C/EBPa. This ob-
servation is reminiscent to the contribution of NLSs of Parp2
or ING1b that contribute to the efﬁciency of nucleolar reten-
tion (Scott et al, 2001; Meder et al, 2005). Serine 299 lies in a
region that is conserved between all C/EBPs and its phos-
phorylation has been associated with opposite effects on
DNA binding and/or subcellular distribution (Mahoney
et al, 1992; Yin et al, 1996; Buck et al, 2001). As we observed
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Figure 8 Selective elimination of extended-C/EBPa impedes rRNA synthesis. (A) Lentiviral shRNA-mediated knock-down of endogenous
human C/EBPa (Ca) compared with control scrambled shRNA (Co) in HL-60 cells. (B) Retroviral-mediated expression in C/EBPa knock-down
HL-60 (shRNA-Ca) cells from rat C/EBPa (wta) or the DCUGa mutant cDNAs. (C) Retroviral-mediated expression of extended-C/EBPa and the
DNoLS mutant thereof in C/EBPa knock-down HL-60 (shRNA-Ca) cells. Immunoblots were probed with anti-C/EBPa antibodies (14AA), and
with anti-a-tubulin antibodies for loading control. The Xa-labelled band is of indeﬁnite C/EBPa origin; possibly sumoylated truncated-C/EBPa
(data not shown). Asterisk (*) indicates non-speciﬁc bands. Levels of 45S pre-rRNAwere measured by Northern blotting of 15mg of total RNA.
Ethidium bromide (EtBr) inverted staining of the gel was used for loading control.
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type extended-C/EBPa isoform, the percentage of cells with
nucleolar localization of extended-C/EBPa continuously in-
creases, a physiological mechanism must exist that stimulates
nucleolar retention and thereby provides a proliferation or
survival advantage for the cells. To adequately address which
signalling pathways could be involved, a more comprehen-
sive experimental setup is required.
Translation from non-AUG initiation codons
Expression of the extended translational isoform of C/EBPa
depends on initiation from non-AUG codons, CUGs in murine
and GUG in human C/EBPa transcripts, respectively (Figure 1).
The molecular mechanisms of selection of alternative non-AUG
codons for initiation are still largely unknown; however, a study
by Schwab et al (2004) indicates that a subset of ribosomes is
scanning speciﬁcally for CUG initiation codons. Several studies
point to a physiological role of selection of non-AUG codons in
transcripts of other regulatory proteins, including c-Myc (Hann
et al, 1992; Kim et al,2 0 0 3 ) ,J u n D( S h o r ta n dP f a r r ,2 0 0 2 ) ,F G F 2
(Kevil et al, 1995) and VEGF (Huez et al,2 0 0 1 )( r e v i e w e di n
(Touriol et al, 2003)). The underlying mechanism of trans-
lational upregulation of the extended C/EBPa isoform is cur-
rently under investigation.
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Figure 9 Occupation of rDNA sequences by extended-C/EBPa facilitates UBF-1 and TBP recruitment and induces histone acetylation.
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in vivo
The lack of antibodies that speciﬁcally recognize extended-
C/EBPa and the impossibility to speciﬁcally target the endo-
genous protein by knockdown strategies (all protein isoforms
can be translated from a single mRNA molecule) makes it
technically difﬁcult to address its physiological functions and
sites of action in depth. Nevertheless, we could detect
C/EBPa-speciﬁc nucleolar localization and expression of
extended-C/EBPa in the leukemia cell line HL-60. The con-
comitant loss of both, C/EBPa-speciﬁc nucleolar localization
and extended isoform expression during HL-60 differentiation
provides a good indication that extended-C/EBPa is respon-
sible for the nucleolar staining in the undifferentiated cells.
We presume that expression of extended-C/EBPa is likely to
be timely and spatially restricted only to those few cells that
proliferate in a tissue. Preliminary analysis of primary bone
marrow cells revealed weak but consistent staining of C/
EBPa in the nucleoli as well as detection of an extended
isoform by immunoblotting (data not shown). To uncover
extended-C/EBPa physiology in vivo in more detail, antibo-
dies have to be generated that speciﬁcally recognize this
isoform. In addition, a mouse model in which either expres-
sion of extended-C/EBPa is abrogated by mutation of its
initiation codon by a knock-in approach, or in which
extended-C/EBPa can be induced from a transgene would
be instrumental.
A hypothetical model of a C/EBPa-based translational
switch
During our study, we did not observe that overexpression of
extended-C/EBPa stimulates cell proliferation in the cell lines
tested. The truncated-C/EBPa isoform that is co-regulated
with the extended isoform in HL-60 cells (Figure 4), however,
drives proliferation in several cell types (Lin et al, 1993;
Calkhoven et al, 2000). We would like to propose a hypothe-
tical translational switch model explaining how controlled
translation into extended- and truncated-C/EBPa contributes
to coordination of cell growth and proliferation: the truncated
isoform blocks the anti-proliferative activity of the full-length
isoform in the nucleus; the extended isoform escapes from
this inhibition by relocating to the nucleolus where it stimu-
lates rRNA synthesis as prerequisite for cell growth and
proliferation (Supplementary Figure S6).
By revealing a function of the extended-C/EBPa isoform in
ribosome biogenesis, a new and fascinating aspect of
C/EBPa-mediated control of cell growth and proliferation
emerges. Whether increased extended-C/EBPa expression or
its nucleolar retention might be involved in cancer develop-
ment has to be investigated.
Materials and methods
DNA constructs
The pSG5- and pcDNA3-based rC/EBPa wt and mutant constructs
have been described earlier (Calkhoven et al, 2000). The DNoLS,
S299D and S299A mutations were introduced by site-directed
mutagenesis (Kunkel et al, 1991). Mutations of the hC/EBPa-cDNA-
pcDNA3 were generated by PCR: GTG into ATG (A
opt) or CCC (DA
1)
and removal of the 50UTR (D50). All EGFPconstructs were generated
using EGFP sequences from the pEGFP-N3 plasmid (BD Clontech).
The extended-C/EBPa domain and the corresponding DNoLS–
EGFP-constructs were generated by PCR. The CMV-Myc vector was
kindly provided by Martin Eilers (University of Wu ¨rzburg). The
pHrP2-BH, pTbuc- and pGem3HR plasmids (Mayer et al, 2005) were
kindly provided by Ingrid Grummt (DKFZ, Heidelberg).
Cell culture, transfection, immunoﬂuorescence and cell
volume analysis
HL-60 and U937 cells were propagated in RPMI, all other cells in
DMEM, plus 10% FCS (Invitrogen) at 5% CO2 and 371C, and G-418
(0.8mg/ml) whenever required. HL-60 differentiation was induced
by 200nM phorbol-12-myristate-13-acetate (TPA) for 12h. Cells
were transfected in 5-cm dishes with 5mg plasmid using FUGENE
(Roche) for MEFs, DEAE-dextran for COS-1 (Calkhoven et al, 2000)
or calcium phosphate. Treatments with actinomycin D (50ng/ml;
Sigma) or a-amanitin (50mg/ml; Sigma) were done for 2h before
ﬁxation. For immunostaining, cells were washed twice with PBS,
ﬁxed with 3.7% paraformaldehyde for 10min at 371C, washed three
times with PBS for 5min at RT, permeabilized with 0.3% triton
X-100 for 5min at RT, blocked in 3% BSA in PBS and incubated with
primary antibody (anti-C/EBPa 14AA, C18, N19 or anti-UBF-1 F-9:
1mg/ml, Santa Cruz Biotechnology Inc.); anti-C/EBPa MA1-825
(1mg/ml, ABR Afﬁnity BioReagents); anti-Fibrillarin AFB01 (2.5mg/
ml, Cytoskeleton Inc.) for 45min at RT. After triple washing for
10min with PBS, cells were incubated with Alexa Fluor 488 or 568
conjugated secondary antibodies (Invitrogen) for 45min at RT, then
triple washed again and incubated with DAPI (1mg/ml MeOH) for
15min at RT. After triple washing for 10min with PBS and single
rinsing with H2O at RT, coverslips were mounted with Moviol
(Sigma) onto glass slides. Microscopic analysis was performed with
the ApoTome deconvolution system (Zeiss). Cell volume in
femtoliter was determined using the CASY Model TTC (Innovatis).
Lentiviral and retroviral transduction
HL-60 cells were infected with pLKO.1-puro retroviral constructs
containing shRNAs against human C/EBPa (50-CCG GGC TGG AGC
TGACCAGTG ACA ACTCGAGTTGTC ACTGGTCAG CTC CAG CTT
TTT-30) or non-target shRNA control (Sigma-Aldrich) and propagated
under puromycin selection (1.5mg/ml). Subsequently, HL-60 cells
containing the human C/EBPa-shRNA were retrovirally transduced
using pMSCV-neo-based vectors containing either wt rat C/EBPa-
FLAG cDNA, cDNA containing the DCUG mutation, extended-
C/EBPa
S299D-FLAG, extended-C/EBPa
S299D-DNoLS-FLAG or empty
vector control, and propagated on G418 (1.8mg/ml) in addition.
Co-immunoprecipitation
Hek293T cells (7 10
5) were transfected with 5mg of expression
vectors as indicated. Cells were lysed in 50mM Tris/HCl pH 7.4,
300mM NaCl, 5mM EDTA, 1% Triton X-100 supplemented with
+10 +30 –10 +20 0
Changein mean cell volume (%)
ExtαS299D
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Figure 10 Overexpression of extended-C/EBPa results in an in-
crease in cell volume. C33A cells expressing empty vector, ex-
tended-C/EBPa-wt, -S299D or -S299D-DNoLS mutants were
analysed for cell volume. The percentage of change in the mean
cell volume compared with empty vector was calculated from two
independent cultures, each measured in triplicate. The error bars
represent the data variation.
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pre-cleared for 30min with Protein G-Sepharose beads (Amersham)
and incubated for 4h with 1mg of primary antibody (anti-UBF-1
(F-9), anti-C/EBPa (14AA), anti-TBP (N-12), anti-TAFI48 (M19)
or normal mouse, rabbit or goat IgG, respectively, as negative
control (all Santa Cruz Biotechnology), which had been coupled to
Protein G-Sepharose beads before (1h incubation in 1 PBS).
Beads were then washed ﬁve times for 5min with 50mM Tris/HCl
pH 7.4, 300mM NaCl, 5mM EDTA 0.1% TritonX-100 supplemented
with 1mM PMSF and protease inhibitor cocktail and once with
1 PBS. Proteins were eluted by boiling the beads in SDS sample
buffer and analysed by western blotting.
Western blotting
Western blotting was performed as described earlier (Calkhoven
et al, 2000) with the following antibodies: anti-C/EBPa antibodies
(14AA, C-18), anti-Myc antibody (9E10), anti-UBF-1 (F-9), antibody
anti-TBP (N-12), anti-TAFI48 (M19), anti-a-Tubulin (TU-02) all from
Santa Cruz Biotechnology, anti-NPM (clone FC-61991) from
Zymed Laboratories), HRP-conjugated seconary antibodies (Amer-
sham Life Technologies or Santa Cruz Biotechnology). Bands
were visualized by chemiluminescence (ECL, Amersham Life
Technologies).
Chromatin immunoprecipitation
C33A cells expressing extended-C/EBPa, extended-C/EBPa
S299D,
extended-C/EBPa
S299DDNoLS or control cells containing the empty
pcDNA3 vector were cultured in DMEM with 10% FBS. ChIP assay
was performed with B5 10
6 cells essentially as described in Puig
et al (2003) using a Bioruptor (Diagenode, Inc.) for sonication
(details on request). ChIP antibodies were against C/EBPa (14AA),
UBF-1 (F-9), TBP (N-12) and non-speciﬁc rabbit IgG from Santa
Cruz Biotechnology, acetylated histone H3 (#06-599) and acetylated
histone H4 (#06-866) from Upstate Biotechnologies. The fold
enrichment was calculated relative to the background detected
with non-speciﬁc rabbit IgG. For the semi-quantitative PCR, 1/50
(1ml) of DNA obtained from the ChIP assay was used as template
in a PCR reaction with 28 cycles. Primer pairs were for Cp (89bp)
50-ccc ggg gga ggt ata tct tt-30 and 50-cca acc tct ccg acg aca-30, for Cd
(114bp) 50-aaa tag gac gga gaa cgt agc-30 and 50-gtt aca ttg ccc gaa
aga tgg-30 for M (155bp) 50-aga ggg gct gcg ttt tcg gcc-30 and 50-cga
gac aga tcc ggc tgg cag-30.
rRNA minigene reporter assay and Northern blotting
The rRNA minigene reporter assay was performed as described in
Mayer et al (2005) using transfection of Hek293T cells with 8mg
reporter plasmid (pHrP2-BH) and 1 or 2.5mg of pcDNA3-based C/
EBPa expression vectors, supplemented with empty pcDNA3
plasmid to a total amount of 10.5mg. For analysis by Northern
blotting, 10mg of total RNA was isolated 40h later using the
guanidine isothiocyanate method. For detection of the 45S rRNA
transcript, cells were serum starved for 24h, replenished with
serum for 4h in the absence or presence of 50mg a-amanitin
following total RNA isolation. A measure of 30mg of total RNAwere
analysed by Northern blotting using a probe from the pGem3HR
plasmid (Mayer et al, 2005) and Northern with a b-actin probe or
ethidium bromide staining was used as loading control.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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